Stay updated on Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.

Latest updates to the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page
- Check7 days agoChange DetectedA new revision label v3.6.4 appears in the history, replacing the previous v3.6.3. This indicates the page was updated to a newer build.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new version entry dated 2026-07-02 was added to the record history, updating the Study Status and Contacts/Locations sections (with an associated 2026-07-01 entry and a 444 marker). The 2026-06-15 entry was deleted.SummaryDifference0.1%

- Check35 days agoChange DetectedA new revision tag Revision: v3.6.3 was added to the record history and the older Revision: v3.6.0 tag was removed, updating the revision list shown for the study’s history.SummaryDifference0.0%

- Check42 days agoChange DetectedA new version entry (443) was added on 2026-06-12 introducing the Study Status and Contacts/Locations sections to the record history, and the last update date was set to 2026-06-15; a 2026-05-29 entry was removed.SummaryDifference0.1%

- Check50 days agoChange DetectedThe record history now shows that recruitment has ceased, indicating the study is no longer enrolling participants. The history also reflects a new revision (v3.6.0) and the removal of the prior revision (v3.5.5), indicating updates to the study documentation.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 on the page. This indicates a small internal update to the site's history display rather than changes to study information.SummaryDifference0.0%

Stay in the know with updates to Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.